Literature DB >> 8592999

Emergence of multiple-antibiotic-resistant Streptococcus pneumoniae in Hong Kong.

K M Kam1, K Y Luey, S M Fung, P P Yiu, T J Harden, M M Cheung.   

Abstract

Two hundred four strains of Streptococcus pneumoniae isolated in Hong Kong from January 1993 to May 1995 were analyzed for their antibiotic susceptibilities and epidemiological patterns. The ages of the patients from whom the strains were isolated from 1 month to 93 years (median, 53 years); the male-to-female ratio was 2.8, with a predominance of males in the pediatric group. Fifty-nine (28.9%) strains showed reduced penicillin susceptibility, including 40 (19.6%) with frank penicillin resistance (MIC > 1 microgram/ml). Tetracycline resistance alone was found in 28.4% of strains. Isolates with reduced penicillin susceptibility were more common in children than adults (40 versus 23.9%, P = 0.02), and penicillin resistance rates were significantly higher in hospitalized patients than in outpatients (39.5 versus 12.5%; p < 0.001). Penicillin resistance was significantly associated with resistance to ceftriaxone, erythromycin, and tetracycline (P < 0.01) but not with ofloxacin or vancomycin (P = 0.5). Among eight different patterns of resistance to three or more antibiotics, the commonest one (14.2%) was multiple resistance to penicillin, chloramphenicol, ceftriaxone, erythromycin, and tetracycline. Emergence of multiple-antibiotic-resistant S. pneumoniae reflects changes in the pneumococcus itself and the general indiscriminate use of antibiotics in treatment of respiratory infections in Hong Kong.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8592999      PMCID: PMC163009          DOI: 10.1128/AAC.39.12.2667

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  Recurrent meningitis from a multiply resistant Streptococcus pneumoniae strain treated with erythromycin.

Authors:  J Alonso; V Madrigal; M García-Fuentes
Journal:  Pediatr Infect Dis J       Date:  1991-03       Impact factor: 2.129

2.  Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin.

Authors:  E Pérez-Trallero; J M Garcia-Arenzana; J A Jimenez; A Peris
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

3.  Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989.

Authors:  A Fenoll; C Martín Bourgon; R Muñóz; D Vicioso; J Casal
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

4.  Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics.

Authors:  J S Bradley; J D Connor
Journal:  Pediatr Infect Dis J       Date:  1991-11       Impact factor: 2.129

5.  Capsular types and antibiotic sensitivity of pneumococci isolated from patients with serious infections in Belgium 1980 to 1988.

Authors:  J Verhaegen; Y Glupczynski; L Verbist; M Blogie; J Vandeven; E Yourassowsky; J Vandepitte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-06       Impact factor: 3.267

Review 6.  Antimicrobial resistance in Streptococcus pneumoniae: an overview.

Authors:  P C Appelbaum
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

7.  Pneumococcal antimicrobial resistance: the problem in Hungary.

Authors:  A Marton
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

8.  In-vitro activity of pefloxacin compared with six other quinolones.

Authors:  E E Ligtvoet; T Wickerhoff-Minoggio
Journal:  J Antimicrob Chemother       Date:  1985-10       Impact factor: 5.790

9.  Treatment of respiratory tract infections with ciprofloxacin.

Authors:  S Raoof; C Wollschlager; F Khan
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

10.  Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis.

Authors:  I R Friedland; K P Klugman
Journal:  Lancet       Date:  1992-02-15       Impact factor: 79.321

View more
  19 in total

1.  Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong.

Authors:  P L Ho; T L Que; D N Tsang; T K Ng; K H Chow; W H Seto
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network.

Authors:  L McGee; L McDougal; J Zhou; B G Spratt; F C Tenover; R George; R Hakenbeck; W Hryniewicz; J C Lefévre; A Tomasz; K P Klugman
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

3.  Macrolide resistance in Streptococcus pneumoniae: Fallacy or fact?

Authors:  Jm Conly; Bl Johnston
Journal:  Can J Infect Dis       Date:  2002-01

4.  Can the choice of antibiotics for therapy of acute otitis media be logical?

Authors:  R Dagan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

5.  Evaluating treatment protocols to prevent antibiotic resistance.

Authors:  S Bonhoeffer; M Lipsitch; B R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

6.  Variation in erythromycin and clindamycin susceptibilities of Streptococcus pneumoniae by four test methods.

Authors:  E L Fasola; S Bajaksouzian; P C Appelbaum; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

7.  Nasal carriage in Vietnamese children of Streptococcus pneumoniae resistant to multiple antimicrobial agents.

Authors:  C M Parry; T S Diep; J Wain; N T Hoa; M Gainsborough; D Nga; C Davies; N H Phu; T T Hien; N J White; J J Farrar
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

8.  MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci.

Authors:  G A Pankuch; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

9.  Evidence of clonal dissemination of multidrug-resistant Streptococcus pneumoniae in Hong Kong.

Authors:  M Ip; D J Lyon; R W Yung; C Chan; A F Cheng
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

Review 10.  Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.

Authors:  Françoise Van Bambeke; René R Reinert; Peter C Appelbaum; Paul M Tulkens; Willy E Peetermans
Journal:  Drugs       Date:  2007       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.